1. Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study. (December 2022) Authors: Sawaki, Masataka; Taira, Naruto; Uemura, Yukari; Saito, Tsuyoshi; Baba, Shinichi; Kobayashi, Kokoro; Kawashima, Hiroaki; Tsuneizumi, Michiko; Sagawa, Noriko; Bando, Hiroko; Takahashi, Masato; Yamaguchi, Miki; Takashima, Tsutomu; Nakayama, Takahiro; Kashiwaba, Masahiro; Mizuno, Toshiro; Yamamoto, ... Journal: Breast Issue: Volume 66(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benign phyllodes tumour with intraductal papillary growth of the breast in a young woman. Issue 2 (30th September 2011) Authors: Yamaguchi, Rin; Tanaka, Maki; Yamaguchi, Miki; Takazaki, Emi; Isobe, Makoto; Terasaki, Hiroshi; Hirai, Yoshitake; Yano, Hirohisa Journal: Journal of clinical pathology Issue: Volume 65:Issue 2(2012) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note. Issue 3 (23rd September 2013) Authors: Yamaguchi, Rin; Tanaka, Maki; Tse, Gary M; Yamaguchi, Miki; Terasaki, Hiroshi; Nomura, Yoriko; Takenaka, Miki; Naito, Yoshiki; Akiba, Jun; Yano, Hirohisa Journal: Journal of clinical pathology Issue: Volume 67:Issue 3(2014) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD8+ tumor‐infiltrating lymphocytes contribute to spontaneous "healing" in HER2‐positive ductal carcinoma in situ. (6th April 2016) Authors: Morita, Michi; Yamaguchi, Rin; Tanaka, Maki; Tse, Gary M.; Yamaguchi, Miki; Kanomata, Naoki; Naito, Yoshiki; Akiba, Jun; Hattori, Satoshi; Minami, Shigeki; Eguchi, Susumu; Yano, Hirohisa Journal: Cancer medicine Issue: Volume 5:Number 7(2016:Jul.) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diverse histomorphology of HER2‐positive breast carcinomas based on differential ER expression. Issue 4 (3rd February 2020) Authors: Akashi, Momoko; Yamaguchi, Rin; Kusano, Hironori; Obara, Hitoshi; Yamaguchi, Miki; Toh, Uhi; Akiba, Jun; Kakuma, Tatsuyuki; Tanaka, Maki; Akagi, Yoshito; Yano, Hirohisa Journal: Histopathology Issue: Volume 76:Issue 4(2020) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study. (16th March 2022) Authors: Kawaguchi, Hidetoshi; Yamamoto, Yutaka; Saji, Shigehira; Masuda, Norikazu; Nakayama, Takahiro; Aogi, Kenjiro; Anan, Keisei; Ito, Yoshinori; Ohtani, Shoichiro; Sato, Nobuaki; Takano, Toshimi; Tokunaga, Eriko; Nakamura, Seigo; Hasegawa, Yoshie; Hattori, Masaya; Fujisawa, Tomomi; Morita, Satoshi; Ya... Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 6(2022) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. (2nd January 2018) Authors: Kawaguchi, Hidetoshi; Masuda, Norikazu; Nakayama, Takahiro; Aogi, Kenjiro; Anan, Keisei; Ito, Yoshinori; Ohtani, Shoichiro; Sato, Nobuaki; Saji, Shigehira; Takano, Toshimi; Tokunaga, Eriko; Nakamura, Seigo; Hasegawa, Yoshie; Hattori, Masaya; Fujisawa, Tomomi; Morita, Satoshi; Yamaguchi, Miki; Yam... Journal: Current medical research and opinion Issue: Volume 34:Number 1(2018) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer. Issue 22 (1st August 2021) Authors: Taira, Naruto; Sawaki, Masataka; Uemura, Yukari; Saito, Tsuyoshi; Baba, Shinichi; Kobayashi, Kokoro; Kawashima, Hiroaki; Tsuneizumi, Michiko; Sagawa, Noriko; Bando, Hiroko; Takahashi, Masato; Yamaguchi, Miki; Takashima, Tsutomu; Nakayama, Takahiro; Kashiwaba, Masahiro; Mizuno, Toshiro; Yamamoto, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 22(2021) Page Start: 2452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Management of breast papillary lesions diagnosed in ultrasound‐guided vacuum‐assisted and core needle biopsies. Issue 4 (20th January 2015) Authors: Yamaguchi, Rin; Tanaka, Maki; Tse, Gary M; Yamaguchi, Miki; Terasaki, Hiroshi; Hirai, Yoshitake; Nonaka, Yasuhide; Morita, Michi; Yokoyama, Toshiro; Kanomata, Naoki; Naito, Yoshiki; Akiba, Jun; Yano, Hirohisa Journal: Histopathology Issue: Volume 66:Issue 4(2015) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells. (July 2019) Authors: Tada, Makoto; Sumi, Toshiyuki; Tanaka, Yusuke; Hirai, Sachie; Yamaguchi, Miki; Miyajima, Masahiro; Niki, Toshiro; Takahashi, Hiroki; Watanabe, Atsushi; Sakuma, Yuji Journal: Lung cancer Issue: Volume 133(2019) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗